Skip to main content

Table 2 Baseline characteristics according to categories of abnormal glucose metabolism based on IEC HbA1c-based definition

From: HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study

Variables

NGT

N = 527

Prediabetes

N = 419

DM

N = 586

P value

Age (years)

56.68 ± 9.93

60.63 ± 9.49

60.47 ± 9.14

 < 0.0001

Female (%)

150/527 (28.46)

129/419 (30.79)

209/586 (35.67)

0.0312

Hypertension (%)

304/527 (57.69)

272/419 (64.92)

437/586 (74.57)

 < 0.0001

Hyperlipidemia (%)

270/527 (51.23)

263/419 (62.77)

382/586 (65.19)

 < 0.0001

Smoke (%)

233/527 (44.21)

170/419 (40.57)

265/586 (45.22)

0.3216

Alcohol (%)

254/527 (48.20)

190/419 (45.35)

252/586 (43.00)

0.2208

BMI (kg/m2)

25.18 ± 3.02

25.73 ± 3.07

26.22 ± 3.26

 < 0.0001

HR (bpm)

68.66 ± 9.69

69.62 ± 10.38

71.30 ± 12.15

0.0002

SBP (mmHg)

127.09 ± 16.24

126.45 ± 16.40

129.03 ± 16.37

0.0624

LVEF (%)

64.77 ± 5.88

65.10 ± 6.68

64.45 ± 6.50

0.4097

NT-proBNP (pmol/L)

537.40 (427.40, 693.90)

550.95 (441.90, 703.20)

547.15 (432.75, 737.35)

0.4443

hsCRP (mg/L)

1.01 (0.54, 1.88)

1.36 (0.67, 2.64)

1.56 (0.80, 3.08)

 < 0.0001

Cr (umol/L)

72.94 (63.17, 82.35)

73.25 (64.00, 80.95)

72.60 (62.62, 82.38)

0.8906

D_Dimer (ug/ml)

0.26 (0.18, 0.37)

0.28 (0.20, 0.39)

0.29 (0.20, 0.41)

0.0005

TC (mmol/L)

4.22 (3.56, 4.87)

4.14 (3.48, 4.86)

4.04 (3.38, 4.78)

0.1502

LDL (mmol/L)

2.46 (1.93, 3.10)

2.42 (1.80, 3.08)

2.32 (1.84, 3.00)

0.0953

HDL (mmol/L)

1.10 (0.90, 1.30)

1.08 (0.90, 1.28)

1.02 (0.86, 1.20)

 < 0.0001

Lpa (mg/L)

162.36 (65.18, 320.46)

150.19 (64.42, 334.84)

145.11 (53.53, 358.73)

0.5735

Fasting glucose (mmol/L)

5.03 ± 0.55

5.26 ± 0.57

7.12 ± 2.60

 < 0.0001

HbA1c (%)

5.64 ± 0.24

6.16 ± 0.13

7.26 ± 1.23

 < 0.0001

Angiographic characteristics

 LM (%)

21/527 (3.98)

17/419 (4.06)

16/586 (2.73)

0.4138

 RCA (%)

119/527 (22.58)

82/419 (19.57)

146/586 (24.91)

0.1364

 LAD (%)

349/527 (66.22)

254/419 (60.62)

388/586 (66.21)

0.1240

 LCX (%)

122/527 (23.15)

107/419 (25.54)

196/586 (33.45)

0.0003

 Triple-vessel disease

23/527 (4.36)

9/419 (2.15)

30/586 (5.12)

0.0560

  1. NGT  normal glucose tolerance, DM  diabetes mellitus, BMI body mass index, HR heart rate, SBP systolic blood pressure, LVEF left ventricular ejection fraction, NT-proBNP N-Terminal Pro–B-Type Natriuretic Peptide, hsCRP high-sensitivity C-reactive protein, Cr Creatinine, TC Total cholesterol, LDL low-density lipoprotein, HDL high-density lipoprotein, Lpa  Lipoprotein (a), HbA1c glycated hemoglobin, LM  left main; RCA  right coronary artery, LAD  left anterior descending, LCX  left circumflex artery